We studied the expression of laminin chains in embryonic and adult human kidney by indirect immunofluorescence with monoclonal antibodies (MAbs). In embryonic human kidney, immunoreactivity for laminin al, 01, and yl chains was found in basement membranes (BMs) of primary vesicles, in comma-and S-shaped bodies, and in more mature stages of glomeruli and in tubules. The p2 chain of laminin was absent in the early glomerular structures but was prominent in BMs of maturing glomeruli (GBMs) and Bowman's capsule (BCBMs) and was also detectable in some tubules. Both the p2 and a 2 chains were variably seen in medullary tubule BMs. In adult human kidney, laminin a1 chain was seen in GBMs and all tubule BMs (TBMs) as well as in arterial smooth muscle BMs (SMBMs). Laminin 81 chain reactivity was found in all TBMs, but not in GBMs or SMBMs. In the glomerulus, a distinct mesangial type of reaction was
Introduction
Formation of a basement membrane (BM) is an essential requirement for formation and maintenance of normal epithelial organization (e.g., 2, 5, 12) . Although ultrastructural studies have revealed an essentially similar structure in BMs of various body sites (42) . immunohistochemical studies have given increasing evidence for their organ-specific heterogeneity (8, 36, 54) . Although these studies could not yet define the molecular basis for such heterogeneity, many recent studies have shown that at least part of it reflects an organ-specific expression of cellular fibronectins (e.g., 33, 52) , laminin chains (1, 10,18,25,28,35,44,53 ; for reviews see 15, 25, 50, 55) , variants of Type IV collagen (e.g., 45, 55) , and those of heparan sulfate proteoglycan (41, 51) . Recently, even the different domains of human intestinal epithelium were suggested to differ in their laminin composition (6).
The development of the mammalian nephron represents a complex cascade of events leading to the formation of the glomerulus and the tubules by induction from undifferentiated mesenchymal ' Supported by the Finnish Medical Research Council.
Correspondence to: Ismo Virtanen, MD, Inst. of Biomedicine, Dept. of Anatomy, PO Box 9, FIN-00014 U. of Helsinki, Finland. revealed with the MAbs to pl and a2 chains. The GBMs and SMBMs reacted with MAbs to the 02 chain, but reactivity was lacking in BCBMs. Laminin yl chain immunoreactivity was weakly present in BCBMs, GBMs, and SMBMs. The a3 and p3 chains could not be detected in developing or adult human nephron. The results show that during development the BMs in human nephron undergo distinct changes, laminin 81 chain being transiently co-expressed with a1 chain during early glomerular development and then becoming replaced by the 82 chain, which, on the other hand, disappears from the BCBMs on maturation. The a2 chain appears to emerge in the mesangium late during development. (1
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KEY WORDS: Basement membranes; Bowman's capsule; Development; Glomerulus; K a h n ; Laminin; Merosin; Nephron; Renal tubules. tissue (11.46). Organ culture studies with mouse tissues by using function-blocking antibodies against laminin a1 chain (47, 48) and the a chain of its major cell receptor, the a6131 integrin, (19, 30, 48) revealed an inhibition or perturbation of nephron development and polarization of nephron tubules, thus providing direct evidence for the importance of laminin in these processes.
We have previously shown that the development of human kidney is accompanied by a segment-specific acquisition of expression of various BM-binding integrins (31, 32) . In this work we studied the immunohistochemical expression of laminin chains in BMs of developing and mature human kidney.
Materials and Methods
Adult human kidney specimens (n = 28) were obtained from the clinically normal part of kidneys for patients who underwent surgery for carcinoma at the Jorvi Hospital (Espoo, Finland). Routine histological examination with hematoxylin-eosin staining was used to confirm lack of inflammation or fibrosis. Human fetal 12-to 16-week kidney samples (n = 6) were obtained from immediate autopsy specimens of legal abortions performed because of severe maternal complications 0: from spontaneous abortions resulting from rupture of fetal membranes at Helsinki University Central Hospital (Helsinki, Finland) or at Jorvi Hospital. Tissues were frozen in liquid nitrogen. Frozen sections were rut at 5 pm and fixed in acetone, pre-cooled to -2O"C, for 10 min.
The monoclonal antibodies (MAbs) against laminin chains a1 (clone 4C7), pl (clone 4E10), yl (clone 2E8). a2 (clone 5H2) (16, 17) , and p2 (26) have been characterized earlier. These MAbs were raised against laminin purified from human placenta. The MAbs to al, pl, yl. and a2 were first purchased from Telios (San Diego, CA) and later obtained from Dr. E. Engvall. The MA b against rat a2 chain (clone C4) was provided by Dr. J. Sanes. The rabbit antiserum against a 3 subunit-containing laminin-5 (kalinin) was raised and characterized as described (40) and was kindly provided by Dr. R.P. Burgeson. Dr. Burgeson also kindly provided the MAb BM-140 (39) reacting with the 140 KD 83 subunit of laminin-5 as well as the MAb BM-2 reacting with the 165 KD a 3 subunit of laminin-5 (40) . The polyclonal antibody against EHS laminin was a kind gift from Dr. Paivi Liesi (37) . The MAbs were applied at a concentration of 2 pg/ml and both of the rabbit antisera were diluted 1:400. The optimal dilutions for the MAbs and rabbit antisera were determined by using a panel of normal human tissues and a series of dilutions. The above concentrations and dilutions were selected because they gave a bright signal and low background.
For immunostaining, the frozen sections were exposed to the MAb and then to fluorescein isothiocyanate (FITC)-coupled sheep anti-mouse IgG antiserum (1:300; Jackson Laboratories, West Grove, PA), both for 30 min. For double immunostaining experiments, the specimens were first exposed to the MAbs followed by tetramethylrhodamine isothiocyanate (TR1TC)coupled sheep anti-mouse IgG antiserum (1:300; Jackson), then to rabbit antiserum followed by the FITC-goat anti-rabbit IgG antiserum (1:300, Jackson). In some experiments, TRITC-Uheumpaeus I agglutinin (50 pg/ml; Vector Laboratories, San Mateo, CA) was used in double labeling with the MAbs to identify intertubular capillaries (21) . TRITC-peanut agglutinin (50 pg/ml; PNA, Vector) was used to label distal tubules (22) and rabbit anti-brush border (BB) antiserum (1:lOO) to visualize proximal tubules (14) . For staining controls, omission of the primary MAb or of the antiserum was used. Furthermore, to control the reactivity of the mouse MAbs, the primary antibody was replaced with an irrelevant mouse MAb raised in our laboratory (human placental protein 14).
The specimens were embedded in Na-veronaliglycerol buffer (~1 , pH 8.4) or Mowiol and examined with a Leica Aristoplan microscope equipped with phase-contrast optics and filters for FITC and TRITC fluorescence.
Results

Developing Human Kidney
In frozen sections of developing kidney, the MAb against laminin a 1 chain gave a bright immunoreactivity in the BMs of all develop- 
Adult Human Kidney
In adult human kidney, immunoreactivity for laminin a 1 chain was seen in all TBMs, in the GBMs, weakly in the BCBMs, and in BMs of arterial smooth muscle (SMBMs) (Figure 3a ). Immunoreactivity for laminin pl chain was revealed in all TBMs, brightly in BCBMs, whereas in glomeruli a bright mesangial type of reactivity was revealed (Figure 3b ). The reactivities with all TBMs were confirmed by double immunostaining with rabbit anti-BB and TRITC-PNA, markers for proximal and distal convoluted tubules, respectively (not shown). The SMBMs did not present immunoreactivity for the (31 chain. Immunoreactivity for the laminin yl chain was detected in TBMs, BCBMs, GBMs, and SMBMs (Figure 3c ). Laminin 02 chain immunoreactivity could be localized to GBMs and SMBMs (Figure 3d ) but was lacking in all TBMs and BCBMs. O n the other hand, immunoreactivity for the a 2 chain was bright in the mesangium (Figure 3e ) but was absent elsewhere in the kidney, including the medulla. Immunoreactivity for laminin-5 or its a 3 or (33 chains could not be revealed in adult human nephron. Notably, double immunostaining experiments with TRITC-UEA-I suggested that at least some intertubular capillaries reacted with MAbs to laminin a 1 (Figures 4a and 4b) and (31 chains (Figures 4c and 4d ).
Discussion
The results of the present study show that there are distinct changes in the distribution of laminin chains during embryonic development of human kidney. Such changes have been reported in mouse kidney, but without knowledge of the exact chains detected (3, 4) .
The results also show that, in adult human kidney laminin chain distribution, and accordingly the trimer composition, is highly characteristic for different nephron segments, mostly concurring with the results of Sanes et al. (45) but differing from those of some other studies on mouse (13, 23, 30) or human kidney (23) .
Many recent biochemical and gene sequencing results have revealed the complexity of laminin expression in tissues (for reviews see 7,15, 17, 24, 45, 49, 50) . It now appears that all laminins are heterotrjmers of three chains that are able to independently form network-like structures ( 5 5). Most basement membranes contain one chain forming the long arm (al, a2, or a3; see 7,49) combined with two light chains forming the short arms ( (31-(33,yl, y2; for reviews see 7, 49, 50) . However, it is still unknown whether the different combinations reflect different functional properties, as cell culture studies have not supported this possibility (15). However. it is noteworthy that, also based on cell culture studies. laminin isoforms are differentially recognized by distinct integrin receptors, suggesting that they may indeed be associated with different adhesion properties of BMs (9).
A number of studies by Ekblom et al. (13.29 ; see also 20, and for reviews 12.13) have suggested that both in vivo and in vitro the metanephric mesenchyme in mouse, as well as some other early embryonic tissues, would express prominently the (31 chain of laminin. Our earlier results on integrin distribution show that the undifferentiated mesenchyme between developing epithelial structures is indeed exceptional in its expression of the a1 and a4 integrin subunits (31), but here we could not detect laminin (31 chain immunoreactivity outside the epithelial BMs that could not be explained by. for example, capillaries. However, a distinct fibrillar reactivity was seen in the capsular wall of the kidney.
There are considerable discrepancies between immunohistochemical data and gene expression data regarding the presence, in particular, of laminin a1 chain in human tissues (see, for exam- ple, 3.4.13.29.44.53) . Recently. Tryggvason (50) concluded that laminin a1 chain, combined with (31lyl chains, would be a rare combination in human tissues. These studies, however, neglect the findings of Leblond (34; see also 2) suggesting that the components of basement membranes in adult tissues may turn over slowly if at all, therefore being possibly undetectable by mRNA expression studies.
The specificity of the MAb 4C7 used towards human a1 laminin chain has been shown indirectly by excluding other specificities: it can be concluded that it detects a ubiquitous laminin longarm chain immunohistochemically distinct from other known laminin chains, and biochemically it detects a high molecular weight laminin chain in JAR cell cultures known to express and produce the a1 chain (17.44). Our results with the MAb suggest that immunoreactivity for laminin a1 chain is present in all kidney BMs throughout development and also in adult kidney, in line with recent expression data revealing the al laminin chain mRNA both in fetal and neonatal human kidney (44,53). The results, however, differ from those of Ekblom et al. (13) in mouse kidney. in which the a1 chain was reported only in BMs of proximal tubules. Their immunohistochemical results have later been somewhat disputed on the basis of results in rabbit. guinea pig, and human kidney (45) . Our results revealed, in agreement with previous studies (26.4) ). that the SMBM in kidney contains laminin al-@-(32 but, furthermore, that the intertubule capillaries would contain detectably at least the a1 and (31 chains.
Abrahamson et al. (4) have suggested that there are distinct losses of laminin epitopes during development of mouse GBMs. The present results suggest that this holds true also for human kidney. the (31 chain disappearing from GBMs and the (32 chain from BCBMs. Interestingly, the (31 chain was highly expressed, together with the a1 and yl chains, during a period when the receptor of this heterotrimer, the aG(31 integrin complex, is also prominently expressed in developing human glomerulus (31,32).
The distribution of the (32 chain has been shown to be remarkably restricted to the neuromuscular junction, arteries, and GBMs (15,26,45) . Our results suggest that during development of human nephron it emerges in the GBMs, and is prominent also in BCBMs. at the time when the complex capillary looping process, resulting in the mature glomerular tuft, begins (46). The S chain is not found in the earlier stages of glomerular development, e.g., at the S-shaped body stage. It is therefore tempting to hypothesize that here the (32 laminin-containing complex and perhaps its specific receptor are mediators in the looping process. Such a replicemenr of (31 chain with (32 chain has earlier been described in developing nerve (21) and recently in the maturation of rat glomerulus (43), further implying its developmental role. Although MAbs against human laminin (32 chain were not available for this study, i t is noteworthy that studies in several rat and human tissues have confirmed that the MAb C9 reacts similarly in both species.
The a 2 chain was originally reported to be absent in kidney (35) but later to be faintly expressed in adult human kidney (45).
The present results using the same MAb show, however, that the a2 chain is prominently present in the mesangial area of adult kidney, together with the (31 chain. However, the a2 chain appeared late in development, being undetectable in glomeruli in all our fetal specimens. Such a late emergence for the a2 chain has also been reported during development of mouse skeletal muscle (35) . Recently, Vuolteenaho et al. (53) reported a high expression of the laminin a2 chain in the undifferentiated mesenchyme of human kidney and concluded that the a2 chain is a mesenchymal laminin. Our results do not support that conclusion, as the a2 chain was not detectable in the cortical mesenchyme although it was present in the BMs of scattered cortical tubules and heterogenously in medullary TBMs. Our results do not exclude, of course, production of the mRNA for the a2 chain without subsequent synthesis of the protein, or synthesis followed by a rapid breakdown and not deposition.
It has been proposed on the basis of biochemical and ultrastructural data (38) that, instead of a 1 chain, there would be a novel long-arm chain laminin variant in bovine kidney. Kallunki et al. (28) , on the other hand, suggested the presence of mRNA for a truncated y l chain, y2, thus implying the presence also of the a 3 chain in nephron BMs. Although our results cannot exclude the presence of an additional laminin long-arm chain variant in human nephron, they do not support the latter suggestion, as immunoreactivities for laminin-5 (a3(33y2) or for laminin chains a3
and (33 were not detectable in developing or adult nephron.
The present results show that there are distinct developmentally regulated changes in the expression of distinct laminin chains during development of the human nephron. Elucidation of the corresponding cascade of events for their putative and emerging receptors in vivo and in vitro may provide new insights into our understanding of nephron development.
